BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2019 Published Issues
3 2 1
Editors-in-Chief
  • Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Full Professor, Surgical Oncologist, Department of Urology (hrhpatel@hotmail.com), University Hospital North Norway (UNN), Tromso 9038, Norway
Indexing/Abstracting
The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
ISSN
2218-4333 (online)
Review
Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management 
Daniela Cornelia Lazăr, Mihaela Flavia Avram, Ioan Romoșan, Violetta Văcariu, Adrian Goldiș, Mărioara Cornianu 
World J Clin Oncol 10(3):110-135. Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.110
Basic Study
Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas 
Eva Wimmer, Stephan Ihrler, Olivier Gires, Sylvia Streit, Wolfgang Issing, Christoph Bergmann 
World J Clin Oncol 10(3):136-148. Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Clinical Trials Study
Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma 
Jennifer Wu, Merly Contratto, Krishna P Shanbhogue, Gulam A Manji, Bert H O’Neil, Anne Noonan, Robert Tudor, Ray Lee 
World J Clin Oncol 10(3):149-160. Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.149
Case Report
Plasma cell leukemia - one in a million: A case report 
Akriti G Jain, Mohammed Faisal-Uddin, Abdul K Khan, Mohammed Wazir, Qi Shen, Manoucher Manoucheri 
World J Clin Oncol 10(3):161-165. Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.161